Molecular-biological analysesare advancingour understanding of intractable neurodegenerative diseases including amyotrophic lateral sclerosis (ALS), but radical careis still to be established.This laboratory aim to perform basic scientific research with the perspective of translating these findings into developing methodsof treatment and prevention of these diseases based on stem cell technology.

  • 2019.2.9
    Japan-UK Neuroscience Symposium 2019, Chiba, Japan
    "Development of therapeutics for amyotrophic lateral sclerosis from iPSC research" presented by Dr. Keiko Imamura
  • 2019.2.7
    International Symposium on NEW FRONTIER in NEUROSCIENCE, Kanazawa, Japan
    “iPSCs for neurological disorders: A decade of progress, hurdles, and beyond”


>>All News Topics